Tag: intranasal drug delivery devices market growth analysis

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

#Intranasal Drug Delivery Devices Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?#_x000D_

The intranasal drug delivery devices market has experienced robust expansion in recent years. This sector is anticipated to increase from $65.09 billion in 2025 to $70.77 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.7%. The observed growth in past periods is attributable to the increasing occurrence of respiratory and nasal conditions, the growing utilization of the nasal route for systemic drug delivery, the advancement of self-administration drug devices, a rise in approvals for intranasal therapies, and the broader implementation of outpatient treatment models._x000D_

_x000D_

The intranasal drug delivery devices market is anticipated to show significant expansion in the coming years. It is projected to achieve a value of $99.11 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.8%. This growth over the forecast period can be attributed to the rising development of biologics and vaccines administered nasally, an increasing demand for homecare drug administration, the widening application of intranasal delivery for neurological therapies, growing investments in advanced drug-device combinations, and an enhanced focus on patient compliance solutions. Key trends during this period are expected to include the increasing adoption of precision nasal delivery systems, a rising demand for non-invasive drug administration, the ongoing development of multi-dose nasal devices, the expansion of patient-friendly drug delivery formats, and an increased emphasis on rapid drug absorption._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=45980603&type=smp&name=Intranasal%20Drug%20Delivery%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Intranasal Drug Delivery Devices Market Growth Momentum: What Factors Are Shaping Demand?#_x000D_

The rising occurrence of chronic diseases is projected to propel the future growth of the intranasal drug delivery devices market. Chronic diseases are defined as conditions that persist for 1 year or longer, necessitate ongoing medical attention, restrict daily living activities, or both. Intranasal drug delivery devices are employed to manage chronic diseases by presenting a non-invasive and efficient pathway for medication administration. These devices facilitate the direct delivery of medications to the affected region, offering convenience, ease of use, and promoting quick absorption. For instance, in June 2024, the National Health Service, a UK-based government department, reported that in 2023, the number of individuals in England at risk of developing type 2 diabetes escalated to 3,615,330, an increase from 3,066,330 in 2022, with over half a million (549,000) additional people identified with non-diabetic hyperglycemia, or pre-diabetes. Consequently, the increasing prevalence of chronic diseases is a significant driver for the expansion of the intranasal drug delivery devices market._x000D_

_x000D_

#Intranasal Drug Delivery Devices Market Segmentation And Category Overview#_x000D_

The intranasal drug delivery devices market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products_x000D_

2) By Dosage: Unit-Dose, Multi-Dose_x000D_

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications_x000D_

4) By End User: Hospitals, Clinics, Homecare, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device_x000D_

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device_x000D_

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs_x000D_

4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays_x000D_

_x000D_

#Intranasal Drug Delivery Devices Market Trends Redefining Industry Growth#_x000D_

Leading corporations within the intranasal drug delivery devices market are dedicated to creating enhanced products, including the recyclable polyolefin nasal spray actuator, aiming to boost sustainability, improve patient adherence, and promote eco-friendly drug delivery options. A recyclable polyolefin nasal spray actuator is defined as a nasal drug delivery device component crafted entirely from polyolefin substances, intended for multi-dose applications without any metal parts. For example, in January 2023, Aptar Pharma, a US-based provider of drug delivery and pharmaceutical solutions, introduced the APF Futurity. This pioneering metal-free multidose nasal spray pump was developed to meet the increasing demand for packaging that is highly recyclable. The APF Futurity is constructed entirely from polyolefin materials, incorporates no metal elements, and has secured a Class AA highly recyclable certification from cyclos-HTP. This pump ensures accurate and uniform dosing with gentle operation, is compatible with nasal saline and various other over-the-counter formulations, and facilitates sustainable recycling, thereby making it perfect for environmentally aware drug delivery solutions and user convenience._x000D_

_x000D_

#Intranasal Drug Delivery Devices Market Competitive Overview And Top Companies#_x000D_

Major companies operating in the intranasal drug delivery devices market are Johnson and Johnson Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, 3M Company, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group plc., OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, ENT Technologies Pty. Ltd., Neurelis Inc. _x000D_

_x000D_

#View The Full Intranasal Drug Delivery Devices Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Intranasal Drug Delivery Devices Market Leading Geography: Which Region Contributes The Most Revenue?#_x000D_

North America was the largest region in the intranasal drug delivery devices market in 2025. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Intranasal Drug Delivery Devices Market From 2026 To 2030?

The intranasal drug delivery devices market has shown robust growth over recent years. It is anticipated to increase from $65.09 billion in 2025 to $70.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The expansion observed in the past can be attributed to several factors, including the rising prevalence of respiratory and nasal ailments, the increasing utilization of the nasal route for systemic drug delivery, the development of self-administration drug devices, a greater number of approvals for intranasal therapies, and the broadening of outpatient treatment approaches.

The intranasal drug delivery devices market is projected to experience robust expansion in the coming years, set to reach $99.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing creation of biologics and vaccines for nasal administration, a surging need for drug delivery in homecare settings, the broadening application of intranasal delivery for neurological treatments, increasing financial commitments towards sophisticated drug-device combinations, and a heightened emphasis on solutions that improve patient adherence. Key trends expected throughout this period encompass the growing integration of precision nasal delivery systems, an escalating preference for non-invasive methods of drug administration, the continued evolution of multi-dose nasal devices, a wider array of patient-convenient drug delivery formats, and an intensified focus on achieving quick drug absorption.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp

Which Core Factors Are Supporting The Expansion Of The Intranasal Drug Delivery Devices Market?

The rising prevalence of chronic diseases is projected to stimulate the growth of the intranasal drug delivery devices market in the future. Chronic diseases are defined as conditions that persist for 1 year or more, necessitating ongoing medical attention, limiting daily living activities, or both. Intranasal drug delivery devices are utilized to manage these conditions by offering a non-invasive and effective means of administering medications. They enable direct drug delivery to the affected area, which is convenient, easy to use, and facilitates rapid absorption. For example, in June 2024, the National Health Service, a UK-based government department, reported that in 2023, the count of individuals in England at risk of developing type 2 diabetes climbed to 3,615,330, an increase from 3,066,330 in 2022, with an additional 549,000 people identified with non-diabetic hyperglycemia, or pre-diabetes. Consequently, the increasing prevalence of chronic diseases is a primary driver for the expansion of the intranasal drug delivery devices market.

Which Segment-Based Categories Are Covered In The Intranasal Drug Delivery Devices Market?

The intranasal drug delivery devices market covered in this report is segmented –

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products

2) By Dosage: Unit-Dose, Multi-Dose

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications

4) By End User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs

4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays

Which Trends Are Contributing To Changes In The Intranasal Drug Delivery Devices Market?

Major companies active in the intranasal drug delivery devices market are prioritizing the development of improved products, such as recyclable polyolefin nasal spray actuators, to boost sustainability, enhance patient compliance, and facilitate environmentally friendly drug delivery solutions. A recyclable polyolefin nasal spray actuator is a nasal drug delivery component constructed entirely from polyolefin materials, designed for multiple-dose administration without any metal parts. For example, in January 2023, Aptar Pharma, a US-based drug delivery and pharmaceutical solutions company, introduced the APF Futurity, which is the first metal-free multidose nasal spray pump created to address the increasing demand for highly recyclable packaging. The APF Futurity is made entirely from polyolefin materials, contains no metal components, and possesses a Class AA highly recyclable certification from cyclos-HTP. This pump offers precise and consistent dosing with gentle actuation, is compatible with nasal saline and other over-the-counter formulations, and supports sustainable recycling, thereby making it an ideal option for environmentally conscious drug delivery solutions and patient convenience.

Who Are The Companies Shaping The Intranasal Drug Delivery Devices Market Landscape?

Major companies operating in the intranasal drug delivery devices market are Johnson and Johnson Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, 3M Company, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group plc., OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, ENT Technologies Pty. Ltd., Neurelis Inc.

Access The Complete Intranasal Drug Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

Which Region Stands As The Largest Contributor To The Intranasal Drug Delivery Devices Market?

North America was the largest region in the intranasal drug delivery devices market in 2025. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Intranasal Drug Delivery Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

Browse Through More Reports Similar to the Global Intranasal Drug Delivery Devices Market 2026, By The Business Research Company

Nail Salon Market Report 2026

https://www.thebusinessresearchcompany.com/report/nail-salon-global-market-report

Nail Polish Market Report 2026

https://www.thebusinessresearchcompany.com/report/nail-polish-global-market-report

Medical Tubing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-tubing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Intranasal Drug Delivery Devices Market Expected To Scale Between 2026 And 2030?

The intranasal drug delivery devices market size has demonstrated significant growth over recent years. This market is anticipated to expand from $65.09 billion in 2025 to $70.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The historical growth can be linked to factors such as the increasing prevalence of respiratory and nasal disorders, the rising adoption of the nasal route for systemic drug delivery, the expansion of self-administration drug devices, a rise in approvals for intranasal therapies, and the broader implementation of outpatient treatment models.

The intranasal drug delivery devices market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $99.11 billion, exhibiting a compound annual growth rate (CAGR) of 8.8%. This projected increase during the forecast period is fueled by several factors, including the rising creation of biologics and vaccines delivered nasally, a growing need for homecare drug management, the wider application of intranasal methods for neurological treatments, increasing capital directed towards sophisticated drug-device combinations, and a greater emphasis on solutions that enhance patient adherence. Key market tendencies expected in this period encompass the wider acceptance of precise nasal delivery systems, an escalating preference for non-invasive drug administration, the ongoing development of multi-dose nasal devices, the proliferation of user-friendly drug delivery options, and an intensified focus on achieving quick drug absorption.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp

What Major Factors Are Driving The Intranasal Drug Delivery Devices Market Forward?

The rising incidence of chronic diseases is anticipated to propel the growth of the intranasal drug delivery devices market going forward. Chronic diseases are defined as conditions lasting a year or more, necessitating ongoing medical attention, restricting daily living activities, or both. Intranasal drug delivery devices are utilized to manage chronic diseases by offering a non-invasive and efficient method for administering medications. They facilitate direct delivery of drugs to the target area, providing convenience, ease of use, and promoting quick absorption. For example, in June 2024, data from the National Health Service, a UK-based government department, revealed that in 2023, the number of individuals in England at risk of developing type 2 diabetes increased to 3,615,330, up from 3,066,330 in 2022, with an additional over half a million (549,000) people identified with non-diabetic hyperglycemia, or pre-diabetes. Consequently, the increasing prevalence of chronic diseases is a significant driver for the growth of the intranasal drug delivery devices market.

How Is The Intranasal Drug Delivery Devices Market Segmented Across Different Segment Categories?

The intranasal drug delivery devices market covered in this report is segmented –

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products

2) By Dosage: Unit-Dose, Multi-Dose

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications

4) By End User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs

4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays

Which Trends Are Impacting The Progress Of The Intranasal Drug Delivery Devices Market?

Leading companies within the intranasal drug delivery devices market are concentrating on developing novel and improved products, such as recyclable polyolefin nasal spray actuators. This focus aims to bolster sustainability, enhance patient compliance, and support eco-friendly drug delivery solutions. A recyclable polyolefin nasal spray actuator is a nasal drug delivery component crafted entirely from polyolefin materials, engineered for multiple-dose administration without any metal parts. For instance, in January 2023, Aptar Pharma, a US-based drug delivery and pharmaceutical solutions company, unveiled the APF Futurity. This represents the first metal-free multidose nasal spray pump, specifically designed to address the rising demand for highly recyclable packaging. The APF Futurity is manufactured entirely from polyolefin materials, contains no metal components, and possesses a Class AA highly recyclable certification from cyclos-HTP. This pump delivers precise and consistent dosing with gentle actuation, is compatible with nasal saline and other over-the-counter formulations, and facilitates sustainable recycling, thereby making it an optimal choice for environmentally conscious drug delivery solutions and patient convenience.

Which Organizations Play A Role In The Intranasal Drug Delivery Devices Market Landscape?

Major companies operating in the intranasal drug delivery devices market are Johnson and Johnson Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, 3M Company, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group plc., OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, ENT Technologies Pty. Ltd., Neurelis Inc.

Get The Full Intranasal Drug Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

Where Is The Intranasal Drug Delivery Devices Market Primarily Concentrated By Region?

North America was the largest region in the intranasal drug delivery devices market in 2025. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Intranasal Drug Delivery Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp

Browse Through More Reports Similar to the Global Intranasal Drug Delivery Devices Market 2026, By The Business Research Company

Nail Salon Market Report 2026

https://www.thebusinessresearchcompany.com/report/nail-salon-global-market-report

Nail Polish Market Report 2026

https://www.thebusinessresearchcompany.com/report/nail-polish-global-market-report

Medical Tubing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-tubing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Intranasal Drug Delivery Devices Market Expected To Change Between 2026 And 2030?

The intranasal drug delivery devices market size has shown significant expansion in recent years. It is anticipated to increase from $65.09 billion in 2025 to $70.77 billion in 2026, registering a compound annual growth rate (CAGR) of 8.7%. The historical growth of this market is attributable to the growing occurrence of respiratory and nasal disorders, the increasing adoption of the nasal route for systemic drug delivery, the rise of self-administration drug devices, an increase in approvals for intranasal therapies, and the expansion of outpatient treatment models.

The intranasal drug delivery devices market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $99.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8%. This projected growth is driven by factors such as the increasing creation of biologics and vaccines for nasal administration, a surging need for home-based drug delivery, broader application of intranasal methods for neurological treatments, escalating investments in sophisticated drug-device innovations, and a heightened emphasis on solutions that improve patient adherence. Key trends anticipated during this period encompass the wider embrace of precision nasal delivery systems, an escalating preference for non-invasive drug application, the advancement of multi-dose nasal devices, a diversification of patient-friendly drug delivery formats, and a sharper focus on achieving swift drug absorption.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp

What Drivers Are Expected To Influence The Intranasal Drug Delivery Devices Market During The Forecast Period?

The growing occurrence of chronic ailments is projected to boost the expansion of the intranasal drug delivery devices market in the future. These are health conditions enduring a year or longer, necessitating continuous medical care, restricting daily activities, or both. Intranasal drug delivery systems offer a non-invasive and effective method for administering medicines, thus aiding in the management of chronic diseases. Such devices facilitate direct delivery of drugs to the target region, offering convenience, ease of use, and quick absorption. As an illustration, data from June 2024, released by the National Health Service, a UK-based government department, revealed that in 2023, the population in England vulnerable to type 2 diabetes climbed to 3,615,330, an increase from 3,066,330 in 2022. This included an identification of more than 549,000 extra individuals with non-diabetic hyperglycemia, also known as pre-diabetes. Consequently, the rising incidence of chronic illnesses is fueling the expansion of the intranasal drug delivery devices market.

How Is The Intranasal Drug Delivery Devices Market Structured Across Different Segments?

The intranasal drug delivery devices market covered in this report is segmented –

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products

2) By Dosage: Unit-Dose, Multi-Dose

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications

4) By End User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs

4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays

Which Trends Are Shaping The Future Of The Intranasal Drug Delivery Devices Market?

Major companies in the intranasal drug delivery devices market are concentrating on creating innovative and improved products, such as recyclable polyolefin nasal spray actuators, to boost sustainability, enhance patient compliance, and support environmentally sound drug delivery solutions. A recyclable polyolefin nasal spray actuator constitutes a nasal drug delivery component made entirely from polyolefin materials, designed for multiple-dose administration without any metal parts. For instance, in January 2023, Aptar Pharma, a US-based drug delivery and pharmaceutical solutions company, introduced the APF Futurity, the first metal-free multidose nasal spray pump engineered to address the increasing demand for highly recyclable packaging. The APF Futurity is composed entirely of polyolefin materials, contains no metal components, and holds a Class AA highly recyclable certification from cyclos-HTP. This pump offers precise and consistent dosing with gentle actuation, is compatible with nasal saline and other over-the-counter formulations, and facilitates sustainable recycling, making it ideal for environmentally conscious drug delivery solutions and patient convenience.

Which Major Players Dominate The Intranasal Drug Delivery Devices Market?

Major companies operating in the intranasal drug delivery devices market are Johnson and Johnson Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, 3M Company, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group plc., OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, ENT Technologies Pty. Ltd., Neurelis Inc.

Read the full intranasal drug delivery devices market report here:

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

Which Region Is Forecast To Lead The Intranasal Drug Delivery Devices Market In Terms Of Market Size?

North America was the largest region in the intranasal drug delivery devices market in 2025. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Intranasal Drug Delivery Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp

Browse Through More Reports Similar to the Global Intranasal Drug Delivery Devices Market 2026, By The Business Research Company

Nail Salon Market Report 2026

https://www.thebusinessresearchcompany.com/report/nail-salon-global-market-report

Nail Polish Market Report 2026

https://www.thebusinessresearchcompany.com/report/nail-polish-global-market-report

Medical Tubing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-tubing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Intranasal Drug Delivery Devices Market?

The market for intranasal drug delivery devices has experienced significant expansion over recent years. Forecasts indicate it will expand from $65.09 billion in 2025 to $70.77 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.7%. This historical growth is linked to factors such as the rising incidence of respiratory and nasal conditions, the growing adoption of the nasal pathway for systemic drug administration, the proliferation of self-administration drug devices, a surge in approvals for intranasal treatments, and the wider implementation of outpatient care models.

The intranasal drug delivery devices market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $99.11 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.8%. This growth during the forecast period can be attributed to factors such as the increasing development of biologics and vaccines through nasal delivery, the rising demand for drug administration in homecare settings, the expansion of intranasal delivery for neurological therapies, growing investments in advanced drug-device combinations, and an increasing focus on patient compliance solutions. Major trends expected in the forecast period include the increasing adoption of precision nasal delivery systems, a rising demand for non-invasive drug administration, the growing development of multi-dose nasal devices, the expansion of patient-friendly drug delivery formats, and an enhanced focus on rapid drug absorption.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp

What Drivers Are Supporting Technological Adoption In The Intranasal Drug Delivery Devices Market?

The growing occurrence of chronic diseases is anticipated to fuel the expansion of the intranasal drug delivery devices market. Chronic diseases are ailments characterized as conditions that persist for 1 year or more, demanding ongoing medical attention, limiting daily activities, or both. Intranasal drug delivery devices are instrumental in managing chronic diseases by offering a non-invasive and efficient means for medication administration. They facilitate the direct delivery of medications to the target area, which is convenient, straightforward to use, and promotes swift absorption. For example, in June 2024, according to the National Health Service, a UK-based government department, the number of individuals in England at risk of developing type 2 diabetes in 2023 had increased to 3,615,330, up from 3,066,330 in 2022, with an additional over half a million (549,000) people identified with non-diabetic hyperglycemia, or pre-diabetes. Consequently, the rising prevalence of chronic diseases is driving the growth of the intranasal drug delivery devices market.

What Segment Types Are Examined In The Intranasal Drug Delivery Devices Market?

The intranasal drug delivery devices market covered in this report is segmented –

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products

2) By Dosage: Unit-Dose, Multi-Dose

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications

4) By End User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs

4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays

What Trends Are Projected To Support The Growth Of The Intranasal Drug Delivery Devices Market?

Leading companies in the intranasal drug delivery devices market are focused on developing enhanced products, such as recyclable polyolefin nasal spray actuators, to improve sustainability, foster patient compliance, and support environmentally friendly drug delivery solutions. A recyclable polyolefin nasal spray actuator describes a nasal drug delivery component crafted solely from polyolefin materials, engineered for multi-dose administration without any metal parts. For example, in January 2023, Aptar Pharma, a US-based drug delivery and pharmaceutical solutions company, unveiled the APF Futurity, which is the first metal-free multidose nasal spray pump created to meet the rising demand for highly recyclable packaging. The APF Futurity is manufactured entirely from polyolefin materials, contains no metal components, and holds a Class AA highly recyclable certification from cyclos-HTP. This pump provides precise and consistent dosing with gentle actuation, is compatible with nasal saline and other over-the-counter formulations, and promotes sustainable recycling, positioning it as an ideal choice for environmentally conscious drug delivery solutions and patient convenience.

Who Are The Primary Competitors In The Global Intranasal Drug Delivery Devices Market?

Major companies operating in the intranasal drug delivery devices market are Johnson and Johnson Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, 3M Company, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group plc., OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, ENT Technologies Pty. Ltd., Neurelis Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

Which Regions Are Projected To Dominate The Intranasal Drug Delivery Devices Market In The Coming Years?

North America was the largest region in the intranasal drug delivery devices market in 2025. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Intranasal Drug Delivery Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp

Browse Through More Reports Similar to the Global Intranasal Drug Delivery Devices Market 2026, By The Business Research Company

Nail Salon Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nail-salon-global-market-report

Nail Polish Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nail-polish-global-market-report

Medical Tubing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-tubing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Intranasal Drug Delivery Devices Industry Compare Between 2025 And 2029?

Significant expansion has characterized the market for intranasal drug delivery devices recently, projecting an increase from its $60.27 billion valuation in 2024 to $65.09 billion by 2025, reflecting a compound annual growth rate of 8.0%. This robust growth observed during the historical timeframe stems from several contributing factors, including the mounting prevalence of chronic respiratory ailments, heightened patient inclination and adherence to the delivery method, the ease associated with self-dosing, applications specifically designed for pediatric populations, the broadening scope within allergic rhinitis therapies, and an increasing spectrum of applicable conditions.

Anticipation is high for substantial expansion within the intranasal drug delivery devices sector in the coming years, projecting a market valuation reaching $91.05 billion by 2029, fueled by an annual growth rate of 8.8%. This upward trajectory throughout the prediction window is underpinned by several key factors, such as the growing elderly demographic, escalating worldwide prevalence of respiratory ailments, broadened utility in addressing neurological conditions, the shift toward tailored medical treatments, greater emphasis on proactive health measures, and market inroads in developing nations. Significant developments shaping this market during the forecast term involve progress in drug formulation techniques, concentrated efforts on suitability for children and the aged, augmentation in devices designed for personal use, the proliferation of nasal powder inhalers, and the integration of biological agents and peptide-based therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp

Which Industry Drivers Are Expected To Accelerate The Intranasal Drug Delivery Devices Market From 2025 To 2029?

The market for intranasal drug delivery systems is anticipated to expand due to the rising incidence of long-term health conditions, which are characterized as ailments persisting for twelve months or longer, necessitating continuous medical management, restricting everyday functioning, or both.These specialized delivery tools offer a convenient, entirely non-invasive, and highly effective method for administering treatments associated with these enduring conditions, facilitating direct application to the target site, which promotes swift uptake.To illustrate this trend, official data from the UK’s National Health Service in June 2024 indicated that in 2023, the NHS registered an additional 549,000 people in England facing the probability of developing type 2 diabetes, elevating the count of individuals diagnosed with pre-diabetes, or non-diabetic hyperglycemia, under general practitioner care to 3,615,330, a notable jump from the 3,065,825 recorded in 2022, signifying an escalation close to 20%, clearly demonstrating how the surge in chronic ailments fuels the progression of the intranasal medication delivery technology sector.

What Are The Major Segment Types Covered In The Intranasal Drug Delivery Devices Market?

The intranasal drug delivery devicesmarket covered in this report is segmented –

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products

2) By Dosage: Unit-Dose, Multi-Dose

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications

4) By End User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs

4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays

Which Trends Are Impacting The Intranasal Drug Delivery Devices Market?

To maintain their standing within the nasal drug delivery technology sector, significant pharmaceutical entities are focused on innovating and refining offerings, presenting novel avenues for drug administration to their clientele. As an illustration, in the opening month of 2023, AptarGroup, Inc., a pharmaceutical and drug delivery firm situated in the United States, introduced APF Futurity, which is notable as the inaugural recyclable, metal-free, multidose nasal spray designed for administering nasal saline and comparable over-the-counter substances. Constructed wholly from polyolefin substances, APF Futurity completely bypasses the inclusion of metallic elements or any contaminants that hinder the recycling process, thereby facilitating easier sorting for recycling and encouraging a higher proportion of reused materials. A defining characteristic of this device is its fundamentally recyclable construction; this nasal spray pump enjoys the distinction of achieving Class AA certification from cyclos-HTP, confirming its compatibility with European recycling infrastructures.

Which Global Market Leaders Are Shaping The Future Of The Intranasal Drug Delivery Devices Sector?

Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

How Does The Intranasal Drug Delivery Devices Market Perform Across Key Geographic Regions?

North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Intranasal Drug Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp

Browse Through More Reports Similar to the Global Intranasal Drug Delivery Devices Market 2025, By The Business Research Company

Electrophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electrophysiology-devices-and-equipment-global-market-report

Electrosurgical Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electrosurgical-devices-and-equipment-global-market-report

Ent Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ent-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Intranasal Drug Delivery Devices Industry Compare Between 2025 And 2029?

Significant expansion has characterized the market for intranasal drug delivery devices recently, projecting an increase from its $60.27 billion valuation in 2024 to $65.09 billion by 2025, reflecting a compound annual growth rate of 8.0%. This robust growth observed during the historical timeframe stems from several contributing factors, including the mounting prevalence of chronic respiratory ailments, heightened patient inclination and adherence to the delivery method, the ease associated with self-dosing, applications specifically designed for pediatric populations, the broadening scope within allergic rhinitis therapies, and an increasing spectrum of applicable conditions.

Anticipation is high for substantial expansion within the intranasal drug delivery devices sector in the coming years, projecting a market valuation reaching $91.05 billion by 2029, fueled by an annual growth rate of 8.8%. This upward trajectory throughout the prediction window is underpinned by several key factors, such as the growing elderly demographic, escalating worldwide prevalence of respiratory ailments, broadened utility in addressing neurological conditions, the shift toward tailored medical treatments, greater emphasis on proactive health measures, and market inroads in developing nations. Significant developments shaping this market during the forecast term involve progress in drug formulation techniques, concentrated efforts on suitability for children and the aged, augmentation in devices designed for personal use, the proliferation of nasal powder inhalers, and the integration of biological agents and peptide-based therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp

Which Industry Drivers Are Expected To Accelerate The Intranasal Drug Delivery Devices Market From 2025 To 2029?

The market for intranasal drug delivery systems is anticipated to expand due to the rising incidence of long-term health conditions, which are characterized as ailments persisting for twelve months or longer, necessitating continuous medical management, restricting everyday functioning, or both.These specialized delivery tools offer a convenient, entirely non-invasive, and highly effective method for administering treatments associated with these enduring conditions, facilitating direct application to the target site, which promotes swift uptake.To illustrate this trend, official data from the UK’s National Health Service in June 2024 indicated that in 2023, the NHS registered an additional 549,000 people in England facing the probability of developing type 2 diabetes, elevating the count of individuals diagnosed with pre-diabetes, or non-diabetic hyperglycemia, under general practitioner care to 3,615,330, a notable jump from the 3,065,825 recorded in 2022, signifying an escalation close to 20%, clearly demonstrating how the surge in chronic ailments fuels the progression of the intranasal medication delivery technology sector.

What Are The Major Segment Types Covered In The Intranasal Drug Delivery Devices Market?

The intranasal drug delivery devicesmarket covered in this report is segmented –

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products

2) By Dosage: Unit-Dose, Multi-Dose

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications

4) By End User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs

4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays

Which Trends Are Impacting The Intranasal Drug Delivery Devices Market?

To maintain their standing within the nasal drug delivery technology sector, significant pharmaceutical entities are focused on innovating and refining offerings, presenting novel avenues for drug administration to their clientele. As an illustration, in the opening month of 2023, AptarGroup, Inc., a pharmaceutical and drug delivery firm situated in the United States, introduced APF Futurity, which is notable as the inaugural recyclable, metal-free, multidose nasal spray designed for administering nasal saline and comparable over-the-counter substances. Constructed wholly from polyolefin substances, APF Futurity completely bypasses the inclusion of metallic elements or any contaminants that hinder the recycling process, thereby facilitating easier sorting for recycling and encouraging a higher proportion of reused materials. A defining characteristic of this device is its fundamentally recyclable construction; this nasal spray pump enjoys the distinction of achieving Class AA certification from cyclos-HTP, confirming its compatibility with European recycling infrastructures.

Which Global Market Leaders Are Shaping The Future Of The Intranasal Drug Delivery Devices Sector?

Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

How Does The Intranasal Drug Delivery Devices Market Perform Across Key Geographic Regions?

North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Intranasal Drug Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp

Browse Through More Reports Similar to the Global Intranasal Drug Delivery Devices Market 2025, By The Business Research Company

Electrophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electrophysiology-devices-and-equipment-global-market-report

Electrosurgical Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electrosurgical-devices-and-equipment-global-market-report

Ent Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ent-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What is the Anticipated CAGR of the Intranasal Drug Delivery Devices Market, and What Factors Will Drive It?#_x000D_

Over the past few years, the market size for intranasal drug delivery devices has shown robust growth. It is projected to increase from $60.27 billion in 2024 to $65.09 billion in 2025, experiencing a compound annual growth rate (CAGR) of 8.0%. The historical growth period was primarily driven by factors such as an increase in chronic respiratory diseases, patient preference and adherence, convenience of self-administration, pediatric uses, market growth in the treatment of allergic rhinitis, and a broader range of indications._x000D_

_x000D_

The market for intranasal drug delivery devices is predicted to experience robust growth in the coming years, with its size expected to inflate to $91.05 billion in 2029, reflecting an 8.8% compound annual growth rate (CAGR). This growth over the forecast period is primarily driven by factors such as an increasing aging population, escalating global respiratory problems, a broader scope of applications in neurological disorders, trends in personalized medicine, initiatives towards preventive healthcare, and market expansion in developing economies. The forecast period is set to showcase technological advancements in formulations, a focus on applications for children and the elderly, a surge in self-administration devices, nasal powder inhalers, and the inclusion of biologics and peptides._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp_x000D_

_x000D_

#What Are the Major Market Drivers Behind the Rising Adoption of Intranasal Drug Delivery Devices Market?#_x000D_

The intranasal drug delivery devices market is anticipated to witness significant growth due to the escalating prevalence of chronic diseases. These medical conditions typically persist for at least a year and require persistent medical intervention, causing limitations in daily life activities, or sometimes both. Intranasal drug delivery devices serve as an efficient and non-invasive method for administering medications to manage such chronic conditions. These devices offer the advantage of direct medication delivery to the affected area, making them easy to use and allowing for quick absorption. For example, the UK’s National Health Service identified over half a million more (549,000) individuals living in England at potential risk of developing type 2 diabetes in June 2024. This brought the total number of people with non-diabetic hyperglycemia or pre-diabetes registered with a GP up to 3,615,330, marking a noticeable increase from the 3,065,825 recorded in 2022 – approximately a 20% surge. Consequently, the rising incidence of chronic diseases is propelling the expansion of the intranasal drug delivery devices market._x000D_

_x000D_

#Which Key Market Segments Comprise the Intranasal Drug Delivery Devices Market and Drive Its Revenue Growth?#_x000D_

The intranasal drug delivery devicesmarket covered in this report is segmented – _x000D_

_x000D_

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products_x000D_

2) By Dosage: Unit-Dose, Multi-Dose_x000D_

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications_x000D_

4) By End User: Hospitals, Clinics, Homecare, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device_x000D_

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device_x000D_

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs_x000D_

4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Intranasal Drug Delivery Devices Market Expansion Across the Globe?#_x000D_

North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Strategic Trends Steering theIntranasal Drug Delivery Devices Market Direction?#_x000D_

Major pharmaceutical corporations in the nasal drug delivery technology market are focusing on product development to provide new drug delivery methods, thereby solidifying their market position. For example, in January 2023, US-based AptarGroup, Inc., a firm specializing in drug delivery and pharmaceuticals, introduced APF Futurity, the first recyclable, metal-free, multidose nasal spray for delivering nasal saline and similar OTC formulations. APF Futurity is made from polyolefin substances and excludes metal elements or elements that disrupt recycling. This feature lessens the requirement for separation during recycling processes and fosters an increased quality of recycled materials. The product’s defining characteristic is its recyclable design, making it a highly recyclable nasal spray pump that has earned a Class AA certification from cyclos-HTP for recycling processes in Europe._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report_x000D_

_x000D_

#How Is the Intranasal Drug Delivery Devices Market Conceptually Defined?#_x000D_

Intranasal drug delivery devices are medical devices that deliver medications into the nasal cavity. These devices are intended to administer medications directly to the nasal mucosa, which is highly vascularized and has a huge surface area, allowing the drug to be absorbed into the bloodstream quickly. It delivers drugs or therapeutic substances in various forms, including sprays, powders, or liquid solutions, directly into the nasal cavity._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13463_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Intranasal Drug Delivery Devices Market Grown from 2024 to 2025?

There has been significant expansion in the market for intranasal drug delivery devices in recent times. The size of the market, which is expected to move from $60.27 billion in 2024 to a larger size of $65.59 billion by 2025, will witness a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this growth during the historic period include the escalation in chronic respiratory conditions, patient inclinations and adherence, ease of self-medication, pediatric usages, growing market for allergic rhinitis treatments, and a broadening spectrum of applications.

What Growth Rate Is Anticipated for the Intranasal Drug Delivery Devices Market in the Coming Years?

Expectations are high for robust growth in the intranasal drug delivery devices market in the coming years. The market is projected to reach a towering value of $92.05 billion in 2029, with an impressive compound annual growth rate (CAGR) of 8.8%. This anticipated growth, during the forecast period, is believed to stem from factors such as the rise in the aging population, increasing global respiratory conditions, wider applications in neurological disorders, evolving trends in personalized medicine, initiatives towards preventive healthcare, and market expansion in emerging economies. Key trends projected to dominate the forecast period include progression in devising formulation technologies, emphasis on pediatric and geriatric applications, growth in self-administration devices and nasal powder inhalers, and the integration of biologics and peptides.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp

Who Are the Leading Companies in the Intranasal Drug Delivery Devices Market?

Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation

What Are the Key Drivers of the Intranasal Drug Delivery Devices Market?

Escalating rates of chronic illnesses are anticipated to fuel the expansion of the intranasal drug delivery devices market. Chronic diseases, those lasting for a year or longer requiring continual medical intervention, or impacting daily life activities can be managed using intranasal drug delivery devices. These devices offer a non-intrusive and efficacious method of medication administration, enabling treatment to be directly delivered to the affected area, offering convenience, ease of usage and fast assimilation. For example, the UK’s National Health Service announced in June 2024 that in 2023, a further 549,000 individuals in England were identified as being at risk of type 2 diabetes, raising the total population registered with a GP as non-diabetic hyperglycemia, or pre-diabetic, to 3,615,330. This denotes a considerable surge from 3,065,825 in 2022, signifying a near 20% increase. Consequently, the rising prevalence of chronic diseases is fueling the growth of the intranasal drug delivery devices market. The Intranasal Drug Delivery Devices Market is driven by a surge in demand for non-invasive drug conveyance. The growing demand for non-invasive methodologies of drug administration is projected to drive the growth of the intranasal drug delivery device market. Non-invasive drug delivery implies pharmaceutical administration without the need for skin penetration or mucous membrane incision. Intranasal drug delivery devices are employed for non-invasive drug delivery, allowing for easy and effective medication administration via the nose. These devices utilize the rich vascularization and fast absorption of the nose, thereby enhancing drug bioavailability and patient compliance while decreasing the necessity for invasive procedures. In August 2023, The US-based Aesthetic Society reported a significant rise in non-surgical procedures with body contouring, skin treatment, toxins, and micro needling showing growth rates of 31%, 26%, 24%, and 23%, respectively in 2022. Thus, the escalating demand for non-invasive drug delivery forms is propelling the growth of the intranasal drug delivery device market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp

What Are the Key Market Segments in the Intranasal Drug Delivery Devices Industry?

The intranasal drug delivery devices market covered in this report is segmented –

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products

2) By Dosage: Unit-Dose, Multi-Dose

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications

4) By End User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs

4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays

What Are the Latest Trends in the Intranasal Drug Delivery Devices Market?

Leading pharmaceutical firms in the nasal drug delivery technology market are innovating new and enhanced products to offer their clients alternative drug administration techniques and maintain their market standing. For example, in January 2023, AptarGroup, Inc., a pharmaceutical and drug delivery corporation based in the US, introduced the first-ever recyclable, metal-free, multidose nasal spray, APF Futurity, for the delivery of nasal saline and similar over-the-counter (OTC) formulations. APF Futurity is crafted from polyolefin materials, with no inclusion of metal parts or elements that could disrupt recycling. This minimizes the necessity for separation in the recycling process, thereby enhancing the quality of recycled materials. The distinct aspect of this product is its design promoting recyclability; it’s recognized as a highly recyclable nasal spray pump with a Class AA certification from cyclos-HTP for European recycling streams.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

What Are the Key Regional Markets in the Intranasal Drug Delivery Devices Industry?

North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13463

This Report Delivers Insight On:

1. How big is the intranasal drug delivery devices market, and how is it changing globally?

2. Who are the major companies in the intranasal drug delivery devices market, and how are they performing?

3. What are the key opportunities and risks in the intranasal drug delivery devices market right now?

4. Which products or customer segments are growing the most in the intranasal drug delivery devices market?

5. What factors are helping or slowing down the growth of the intranasal drug delivery devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the intranasal drug delivery devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the Intranasal Drug Delivery Devices Market Size From 2025 to 2034?

The market for intranasal drug delivery devices has seen robust growth in the past few years. Its size is projected to increase from $60.27 billion in 2024 to $65.59 billion in 2025, with a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this growth in the historic period include increasing prevalence of chronic respiratory diseases, patient preference and adherence, convenience of self-administration, use in pediatric treatment, market growth in allergic rhinitis treatment, and broadening range of indications.

The market for intranasal drug delivery devices is poised for substantial growth in the coming years, predicted to reach a value of $92.05 billion by 2029, with an annual compound growth rate (CAGR) of 8.8%. Factors contributing to this projected increase during the forecast period include the escalating elderly population, global rise in respiratory complications, widening use in neurological ailments, the trajectory of personalized medicine, initiatives in preventative healthcare, and market infiltration in developing economies. Key trends expected during the forecast period encompass advancements in drug formulation technologies, concentrative efforts on pediatric and elderly applications, the popularity of self-administering devices, the use of nasal powder inhalers, and the integration of biologics and peptides.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Intranasal Drug Delivery Devices Market?

The escalating frequency of chronic illnesses is anticipated to fuel the expansion of the intranasal drug delivery devices market. Chronic illnesses are those that persist for more than a year, necessitating continuous medical care and potentially restricting everyday activities. Intranasal drug delivery devices, which provide a non-invasive and effective method of administering drugs, are utilized to manage these chronic diseases. These devices directly deliver the medication to the targeted area, making it user-friendly and enabling fast absorption. For instance, the National Health Service, a UK-based government department, noted in June 2024 that in 2023 the number of people in England at risk of developing type 2 diabetes increased by 549,000. This took the total number of people with non-diabetic hyperglycemia or pre-diabetes registered with a GP to 3,615,330, a rise of nearly 20% from 3,065,825 in 2022. Hence, the increasing prevalence of chronic diseases is contributing to the growth of the intranasal drug delivery devices market. The augmenting demand for non-invasive drug delivery methods is likely to push the growth of the intranasal drug delivery device market. Non-invasive drug delivery involves introducing pharmaceutical substances into the body without puncturing or making incisions in the skin or mucous membranes. The intranasal drug delivery devices utilized in non-invasive drug delivery enhance the simplicity and effectiveness of drug administration via the nose. These devices leverage the vast network of blood vessels and quick absorption in the nose, thereby increasing drug bioavailability and patient compliance while decreasing the necessity for invasive procedures. For example, The Aesthetic Society, a US-based medical organization, observed in August 2023 that non-surgical procedures in the U.S., such as body contouring, skin treatment, toxins, and micro-needling, grew by 31%, 26%, 24%, and 23% respectively in 2022. Hence, the increasing demand for non-invasive drug delivery methods is bolstering the growth of the intranasal drug delivery device market.

Which Segments in the Intranasal Drug Delivery Devices Offer the Most Growth?

The intranasal drug delivery devices market covered in this report is segmented –

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products

2) By Dosage: Unit-Dose, Multi-Dose

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications

4) By End User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs

4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp

What Are the Fastest-Growing Geographies in the Intranasal Drug Delivery Devices Market?

North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Intranasal Drug Delivery Devices Industry?

Key pharmaceutical players in the nasal drug delivery technology market are continually innovating, creating new and enhanced products to provide customers with alternative ways for drug administration and maintain their standing in the market. As an example, in January 2023, the U.S.-based pharmaceutical and drug delivery company, AptarGroup, Inc., introduced APF Futurity, which is the first recyclable, metal-free, multidose nasal spray used to distribute nasal saline and similar over-the-counter (OTC) formulations. APF Futurity is produced from polyolefin materials and lacks any metal components or elements that can disrupt recycling, thus diminishing the requirement for separation in recycling channels and supporting the increase of high-quality recycled materials. The most distinctive feature of this product is its recyclable design making it a highly recycle-friendly nasal spray pump. It has earned a Class AA certification from cyclos-HTP for recycling channels throughout Europe.

View the full report here:

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

What Are the Key Elements That Define the Intranasal Drug Delivery Devices Market?

Intranasal drug delivery devices are medical devices that deliver medications into the nasal cavity. These devices are intended to administer medications directly to the nasal mucosa, which is highly vascularized and has a huge surface area, allowing the drug to be absorbed into the bloodstream quickly. It delivers drugs or therapeutic substances in various forms, including sprays, powders, or liquid solutions, directly into the nasal cavity.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13463

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model